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Introduction {#sec1}
============

Hematopoietic stem cells (HSCs) are functionally defined cells that display evidence of extensive self-renewal of their ability to generate mature blood cells for the lifetime of the organism and following transplantation into myelosuppressed permissive hosts ([@bib14], [@bib16]). Clonal analyses of serially transplantable mouse HSCs have revealed that cells thus defined are composed of multiple distinct subpopulations that stably propagate specifically restricted abilities to produce different types of mature blood cell types ([@bib5], [@bib15], [@bib33], [@bib51], [@bib59]).

Epigenetic modifications have been shown to be critical for the control of normal hematopoiesis as exemplified by the consequences of alterations incurred by disruption of *de novo* DNA methylation in primitive hematopoietic cells ([@bib12], [@bib49], [@bib52]). Moreover, in long-term HSC populations, lineage-specific enhancers appear to be epigenetically marked ([@bib37]), and regulatory regions show gain or loss of DNA methylation during the differentiation of their progeny ([@bib6], [@bib10]). However, most of the epigenetic measurements underpinning these observations represent consensus values experimentally derived from thousands of cells partially enriched in HSCs or their progeny, thus failing to discern distinct epigenetic states within HSCs. Indeed, heterogeneity in methylation states of single CpGs is a common feature of cells assessed as bulk populations ([@bib1], [@bib19], [@bib28], [@bib29], [@bib47]). In addition, epigenetic heterogeneity has been observed across individual HSCs and clonally amplified HSC populations with preserved lineage potentialities ([@bib19], [@bib61]). Nevertheless, the degree to which heterogeneity in the methylome of HSCs is related to their defining properties remains poorly understood.

Assessment of the methylome of single cells is limited by measurement insensitivity and stochastic missing data. Current analytical strategies for single-cell DNA methylation measurements average DNA methylation in fixed genomic bins ([@bib1], [@bib28], [@bib40], [@bib53]), or over defined genomic regions ([@bib18], [@bib19], [@bib29]). However, in many instances multiple regulatory regions are present within these genomic intervals and the relationship of their activity to average DNA methylation within an interval unknown. This is further complicated by the observations that the methylation state of a single CpG can affect transcription ([@bib3], [@bib20], [@bib24], [@bib32], [@bib41], [@bib43], [@bib56], [@bib63]) by altering transcription factor binding affinity ([@bib50], [@bib60]). Imputation strategies leverage sequence context along with CpG methylation states across single cells to increase the resolution of genomic intervals ([@bib2]). However, inference across cells (as well as sequence context) assumes homogeneity across cells, which is at cross-purposes with the generation of single-cell molecular measurements through the potential to mask rare subpopulations.

To address these limitations, we developed an automated plate-based high-resolution single-cell methylation protocol that we call Post-Bisulfite Adapter Ligation (PBAL), and analyzed the resulting sequence reads with an analytical pipeline (Pairwise Dissimilarity Clustering: PDclust) that leverages the methylation state of individual CpGs. We applied this single-cell methylation framework to profile primitive hematopoietic cells of mouse and human origin to identify epigenetically distinct subpopulations. Deep sampling of the CpG content of individual HSCs allowed for the near complete reconstitution of regulatory states from epigenetically defined subpopulations of HSCs and revealed a high level of redundancy of CpG methylation states within these phenotypically defined hematopoietic cell types.

Results {#sec2}
=======

Post-Bisulfite Adapter Ligation {#sec2.1}
-------------------------------

PBAL is an adaption of the post-bisulfite adapter tagging (PBAT) strategy ([@bib42]) optimized for library diversity. Previous single-cell PBAT-like strategies have used random primers extended with Illumina sequences to enable direct amplification ([@bib1], [@bib53]). When comparing this approach with untagged random priming, we observed that extended randomers generated shorter double-stranded DNA fragments compared with randomers alone, suggesting inefficient priming ([Figure S1](#mmc1){ref-type="supplementary-material"}). To circumvent this we used untagged random primers and ligated Illumina sequencing adapters to the resulting double-stranded DNA fragments. Pooling of single-cell PBAL libraries allowed the number of PCR cycles to be reduced and hence increased library diversity without compromising the minimum yield requirements for Illumina sequencing (see [Experimental Procedures](#sec4){ref-type="sec"}).

We applied this protocol to EPCR^+^CD45^+^CD48^−^CD150^+^ (ESLAM) cells isolated by fluorescence-activated cell sorting from adult mouse bone marrow (see [Experimental Procedures](#sec4){ref-type="sec"}). This extremely rare, phenotypically defined population is of interest because it is the most highly purified (∼40% pure) source of functionally defined mouse hematopoietic cells with durable (\>4--6 months) repopulating activity in transplanted hosts ([@bib5], [@bib33]). As a comparator population, we sorted a related but less HSC-enriched lineage-negative Lin^−^SCA1^+^c-KIT^+^ (LSK) phenotype (∼3% HSCs) ([@bib45]) ([Figure 1](#fig1){ref-type="fig"}A). We also applied our PBAL protocol to the analogously human HSC-enriched Lin^−^CD34^+^CD38^−^CD90^+^CD45RA^−^CD49f^+^ population (hereafter referred to as "CD49f cells") isolated from two different cord blood donors and reported elsewhere ([@bib34], [@bib35]). Approximately 10% of these CD49f cells have long-term repopulating activity in transplanted immunodeficient mice, and contain all of those able to generate progeny with similar activity assessed in secondary hosts ([@bib34], [@bib35], [@bib44]).Figure 1Overview of Experimental Methods(A) Schematic of the phenotypes studied.(B) Schematic of the PBAL method. Cells are lysed in 96-well plates to release genomic DNA (gDNA) and then subjected to bisulfite conversion that simultaneously converts and shears the gDNA into fragments. Random hexamers are then used to regenerate double-stranded DNA that is then end-repaired, a-tailed, and ligated with indexed adapters before low-cycle PCR amplification. Libraries are then pooled and sequenced on an Illumina sequencing platform.See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

Upon isolation, these mouse and human HSC-enriched cells were immediately lysed and fully unmethylated lambda and fully methylated T7 phage controls added, followed by bisulfite conversion and on-bead desulfonation ([@bib13]). The resulting single-stranded DNA was used as a template for random priming to generate double-stranded DNA for multiplexed library construction on an Agilent Bravo liquid handling platform ([Figure 1](#fig1){ref-type="fig"}B). Following library construction and low-cycle PCR amplification, failed wells were identified by qPCR targeted to repetitive sequences in the mouse or human sequences and removed (see [Experimental Procedures](#sec4){ref-type="sec"}) ([Figures S2](#mmc1){ref-type="supplementary-material"}D and S2E). Libraries that passed this quality control (QC) threshold were pooled and sequenced together on an Illumina HiSeq platform.

An average of 38% of the resulting reads from all single cells sequenced aligned to the reference genome, compared with an average of 0.32% for no template controls ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Conversion of unmethylated cytosines was \>99% efficient, while overconversion of methylated cytosines was \<2% ([Table S1](#mmc1){ref-type="supplementary-material"}). An average of 4 million sequence reads were generated per cell, enabling the measurement of the methylation states of 1.2 million CpGs per cell ([Figure S2](#mmc1){ref-type="supplementary-material"}B). *In silico* merging of the resulting sequence reads confirmed that CpG recovery per cell is stochastic ([Figure S2](#mmc1){ref-type="supplementary-material"}C). As an additional QC step, copy-number variation (CNV) in 5-Mb windows was assessed with Control-FREEC ([@bib7]) to identify and remove cells with uneven coverage that may represent biological or technical artifacts ([Figures S2](#mmc1){ref-type="supplementary-material"}F and S2G). After removal of cells that failed any QC step ([Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}), data for 64 LSK cells, 84 ESLAM cells, and 121 CD49f cells were available for analysis.

Methylation Adjacency in Individually Analyzed Cells {#sec2.2}
----------------------------------------------------

CpG methylation states derived from bulk cells are characterized by spatial correlation ([@bib17], [@bib62]) and improvements in differentially methylated region (DMR) detection have been achieved through the development of algorithms that leverage spatial relationships ([@bib23]). Spatial correlation of CpG methylation state derived from bulk measurements has also provided a rationale for assigning the methylation state of single-CpG measurements to all CpGs within a genomic interval in single-cell methylation analyses ([@bib18], [@bib19], [@bib28], [@bib29], [@bib40], [@bib53]). However, the degree to which CpG methylation state is spatially correlated in individual cells has not been studied. To address this question, we calculated the probability that a CpG in single LSK cells was in the same methylation state with neighboring CpGs as a function of their genomic distance ([Figure 2](#fig2){ref-type="fig"}A) and, as a comparator, we generated adjacency measurements from PBAL datasets derived from 10,000 LSK cells using the calculated mean methylation difference between nearby CpGs to account for the continuous nature of bulk data.Figure 2Concordance Analysis of Neighboring Methylated CpGs by Their Genomic Separation(A) A schematic for how adjacency is calculated. For a randomly subsampled number of CpGs (CpG1), the concordance of methylation of 100 CpGs before and after CpG1 was recorded along with their separation.(B) Analysis of bulk versus single LSK cells across CpG sites genome wide. Curves represent the weighted average in 100-bp bins. Horizontal lines indicate the probability that two randomly sampled CpG sites have the same methylation state based on their genome-wide methylation ("baseline concordance"). Baseline concordance was calculated as the probability of sampling two methylated or two unmethylated CpGs, which is equal to the square of the average fractional methylation rate plus 1 minus the square of the average fractional methylation rate.(C) Analysis of bulk versus single cells across selected regions. For each panel, we considered only CpGs as CpG1 if they were found within each genomic feature.

This strategy revealed genome-wide concordance between CpGs up to 1 kb in *cis* in both the single cells and the bulk population, which then decreased to random chance at 2 kb ([Figure 2](#fig2){ref-type="fig"}B). Genome-wide CpG *cis* concordance was consistently higher in bulk compared with single-cell measurements and did not approach random chance at 5 kb, whereas single-cell concordance reached background levels at 4 kb ([Figure 2](#fig2){ref-type="fig"}B). Concordance between *cis* CpGs for single-cell and bulk-cell measurements was largely equivalent within CpG islands and promoters but was higher in bulk compared with single cells in all other genomic contexts ([Figure 2](#fig2){ref-type="fig"}C). In addition, we found that concordance for both single-cell and bulk samples decayed more rapidly within enhancers ([@bib37]) compared with other genomic regions ([Figure 2](#fig2){ref-type="fig"}C). Taken together, these findings suggest that analytical strategies that infer cytosine methylation within large bins (up to 100 kb, [@bib40]) across the whole genome of single cells may lead to oversmoothening of CpG methylation, supporting a need for additional methodologies.

Identification of Epigenetic Subsets within HSC Populations at Single-CpG Resolution {#sec2.3}
------------------------------------------------------------------------------------

Having established that spatial correlation of CpG methylation states decay rapidly toward random chance within 2 kb and are context specific within single cells, we sought to ask whether we could leverage the information content of single CpGs in single-cell methylation datasets. We ([@bib21]) and others ([@bib6], [@bib23], [@bib36]) have developed single-CpG resolution approaches for DMR detection from bulk DNA methylation measurements; however, these fail to address the sparse and stochastic methylation measurements characteristic of single-cell methylomes. To address this, we developed a measure of CpG methylation pairwise dissimilarity (PD) defined as the average of the absolute difference in methylation values at CpGs covered in each pairwise comparison ([Figure 3](#fig3){ref-type="fig"}A). We then calculated Euclidean distances between each pair of cells using their PD values as features and performed hierarchical clustering (PDclust; see [Experimental Procedures](#sec4){ref-type="sec"}).Figure 3Pairwise Analysis of Single Cells Reveals Subsets within the Murine ESLAM Phenotype(A) Schematic showing how the PD values are calculated between all paired comparisons of single cells.(B) ESLAM cells have a lower overall PD compared with LSK cells and all cell types analyzed. Every pairwise comparison between cells denoted on the x axis is summarized as a box plot with the distribution of PD values shown on the y axis. p values were calculated using a two-sided t test.(C) PDclust of CpGs associated with genes implicated in HSC function ([@bib10]) separate ESLAM and LSK cells, with some LSK cells exhibiting an ESLAM epigenetic signature. The rows and columns are symmetrical and represent single cells. The cells are shaded to represent the PD between each pair of cells, with red representing highly dissimilar and yellow representing highly similar. Meth, average genome-wide CpG methylation; cpg_count, number of distinct CpG sites recovered.(D) Same as (C) but instead considering all CpGs regardless of their genomic position.(E) Multidimensional scaling using PD calculated from (C) used directly as input.(F) MDS analysis of (D) reveals group 1 at the epicenter of single ESLAM cells with group 2 surrounding the central cluster.See also [Figures S3--S5](#mmc1){ref-type="supplementary-material"}.

Application of this algorithm to the ELSAM and LSK single-cell datasets showed that ESLAM cells are epigenetically more similar to each other compared with LSK cells (p \< 0.01), consistent with the knowledge that they are functionally less heterogeneous ([Figure 3](#fig3){ref-type="fig"}B). Unsupervised clustering on PDs derived from CpG sites within genomic regions previously implicated in the HSC-to-multipotent progenitor (MPP) transition ([@bib10]) generated two distinct subsets that were differentially enriched in single ESLAM and LSK cells ([Figure 3](#fig3){ref-type="fig"}C). Projection of PDs onto two-dimensional space with multidimensional scaling supported the existence of two epigenetic states defined by distinct DNA methylation signatures ([Figure 3](#fig3){ref-type="fig"}E)---one that was most enriched in the ESLAM population and the other in the LSK cells---with a proportion (13/64) of LSK cells showing an ESLAM-like epigenetic state.

Next, we enumerated PD values from CpGs genome wide to detect epigenetic subsets within the ESLAM and LSK populations. When all available CpG sites were used, PDclust revealed a subgroup of cells with the highest relative homogeneity (group 1) compared with all other cells (group 2) ([Figure 3](#fig3){ref-type="fig"}D). Multidimensional scaling (MDS) analysis confirmed these relationships by revealing a highly similar population (group 1) and a dispersed population (group 2) ([Figure 3](#fig3){ref-type="fig"}F). Group 1 included a higher proportion of ESLAM cells than LSK cells (26/84 versus 3/64 or 31% versus 5%). Interestingly, these proportions closely resemble the published biologically defined HSC content of both of these phenotypically defined populations. MDS plots further revealed a gradual and continuously increasing heterogeneity in the CpG profiles of LSK cells ([Figure 3](#fig3){ref-type="fig"}F). As a negative control, we considered only CpGs within a genomic region set that would not be expected to be relevant in HSCs (cortex enhancers; [@bib26]) and showed no discernible relationships ([Figure S3](#mmc1){ref-type="supplementary-material"}). As an additional validation, we applied PDclust to previously generated methylome data for single human leukemic cells ([@bib18]) and single murine embryonic stem cells ([@bib1], [@bib53]) and separated cells accurately by type and treatment, with an exception for HL60 cells treated with vitamin D ([Figure 4](#fig4){ref-type="fig"}). Taken together, these results suggest that the epigenetic state of a single cell can be accurately described by a small (\<1%) stochastically sampled fraction of CpGs and that these states are reflective of cell identity and state.Figure 4Pairwise Dissimilarity Applied to Existing Datasets Is Able to Distinguish CellsBased on Cell Type and Treatment. (A and B) Clustering (A) and MDS scaling of PD values (B) calculated from HL60 and K562 cells ([@bib18]) separates cells by cell type, and reveals patterns of treatment-induced differentiation. Cells are shaded to represent the pairwise dissimilarity between each pair of cells, with red representing highly dissimilar and yellow representing highly similar. Meth, average genome-wide CpG methylation; cpg_count, number of distinct CpG sites recovered.(C and D) Clustering (C) and MDS scaling (D) of embryonic stem cells ([@bib53], [@bib1]) separates cells by the culture medium in which they were grown, and shows some cells in a transition state.

Function of DMRs in Epigenetically Defined Subgroups of Mouse HSCs {#sec2.4}
------------------------------------------------------------------

To examine the functional significance of the epigenetically defined subsets of LSKs and ESLAM cells, we merged CpG calls *in silico* across all cells belonging to group 1 and separately to group 2 described above. We then inferred methylation values of all CpGs across the genome for these two groups using Bsmooth ([@bib23]) and identified DMRs between the two groups ([Figure S4](#mmc1){ref-type="supplementary-material"}A and [Experimental Procedures](#sec4){ref-type="sec"}). This resulted in the identification of 9,922 DMRs that were hypomethylated in group 1 compared with group 2, and 10,047 DMRs that were the opposite state. For each DMR, we then used HOMER ([@bib25]) to annotate its overlapping genomic feature(s) as well as the nearest gene.

In general, CpG methylation is anti-correlated with expression when found in the promoter region or the first exon of a gene ([@bib9]), and active distal regulatory regions are typically hypomethylated ([@bib55]). We found that DMRs between groups 1 and 2 were enriched in promoters (±2 kb of transcription start site \[TSS\]), depleted in distal intergenic regions, and enriched in evolutionarily conserved genomic elements (Phastcon score \[[@bib54]\]; two-sided t test, p ∼ 0) ([Figure S4](#mmc1){ref-type="supplementary-material"}B). We next looked for subsets of DMRs that were either within the first exon, within the promoter, or intergenic and within 20 kb from an annotated TSS ([@bib36]). We assigned each DMR of this class to the subgroup that reported the lower methylation value and associated each DMR group with the nearest genes using HOMER ([@bib25]). As a control, we performed the same analysis for data merged *in silico* from all LSK and ESLAM single cells. To identify genes uniquely associated with only group 1 or group 2, we removed those associated with DMRs from both populations and subjected the remaining group 1- or group 2-specific genes to gene set enrichment analysis (GSEA). Genes associated with hypomethylated DMRs in group 1 were significantly enriched (false discovery rate \[FDR\] adjusted q value \< 0.1) in HSC proliferation terms as well as genes preferentially expressed in long-term HSCs and erythrocytes ([Figure S4](#mmc1){ref-type="supplementary-material"}C). In contrast, genes associated with hypomethylated group 2 DMRs were enriched in genes specifically expressed in differentiated hematopoietic cells and genes that, when knocked out, lead to increased HSC numbers. Together these results suggest that DMRs specifically hypomethylated in group 1 compared with group 2 are associated with genes implicated in HSC function.

After identifying genes associated with hypomethylated DMRs, we sought to examine their expression in single ESLAM cells. To do this, we used previously generated single-cell RNA-sequencing data from Lin^−^c-KIT^+^SCA1^+^CD34^−^FLT3^−^CD48^−^CD150^+^ HSCs ([@bib57]) and compared the expression of the DMR-associated genes thus identified with all genes. This showed that the DMR-associated genes were expressed at higher levels in these cells as compared with all other genes (p \< 0.01, Mann-Whitney test) ([Figure S5](#mmc1){ref-type="supplementary-material"}A). Further investigation of the levels of expression of these DMR-associated genes within the ESLAM population ([@bib57]) showed that a significant number showed heterogeneous expression profiles as might be expected if they were composed of one or more subpopulations (hypergeometric p value \< 0.01) ([Figure S5](#mmc1){ref-type="supplementary-material"}B). To identify potential surface markers that might allow their physical separation, we identified genes encoding plasma membrane proteins (as defined by gene ontology) and associated these with DMRs that were hypomethylated in group 1. The resulting list included *Cd82* ([Figure S4](#mmc1){ref-type="supplementary-material"}A), a gene encoding a surface protein previously implicated in the maintenance of long-term HSCs *in vivo* ([@bib30]).

Human HSCs and Their Derivatives Can Also Be Defined at Single-CpG Resolution {#sec2.5}
-----------------------------------------------------------------------------

To determine whether single human hematopoietic cells could also be described using PDclust, we generated PBAL datasets for series of single human CD49f cells and obtained previously published datasets for all the major CD34^+^ phenotypes in human cord blood ([@bib19]). Application of PDclust to the latter datasets showed that a majority of megakaryocytes and selected CD49f cells and other CD34^+^ phenotypes had higher PD values and appeared to be outliers from the remaining cells (groups 2 and 3) ([Figures S6](#mmc1){ref-type="supplementary-material"}A--S6C). These outlier cells also demonstrated significantly lower genome-wide average CpG methylation in comparison with all other cells, suggesting that they were either technical or biological outliers ([Figure S6](#mmc1){ref-type="supplementary-material"}D). When they were removed, the single-cell methylome data clustered according to cell phenotype, with some overlap of the CD49f cells and MPPs ([Figure 5](#fig5){ref-type="fig"}A). Multidimensional analysis confirmed separation of CD49f cells and MPPs from other phenotypes and revealed a clear separation of progenitors of granulocytes and macrophages (GMPs) from all other phenotypes ([Figure 5](#fig5){ref-type="fig"}B). This analysis also showed that cells within the same phenotype had a lower dissimilarity as compared with other phenotypes (p \< 0.01 for all comparisons) ([Figure 5](#fig5){ref-type="fig"}C). These results confirm that stochastic measurements of single-CpG states in single cells can accurately segregate multiple primitive phenotypically distinct human hematopoietic cell populations.Figure 5Pairwise Dissimilarities of Human Hematopoietic Cells with Different Phenotypes(A) PD of CD49f and other CD34^+^ subsets separate cells by phenotype with some overlaps. The rows and columns are symmetrical and represent single cells. Cells are shaded to represent the PD between each pair of cells, with red representing highly dissimilar and yellow representing highly similar.(B) MDS of PD values shows that CD49f cells cluster in the middle, with GMPs, CLPs, and MLPs branching out in separate directions.(C) Single cells have lower PD values compared with cells of the same type versus cells of a different phenotype. The distribution of PD values when a cell is compared with either a cell of the same or different phenotype is plotted as a box plot.See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

Sources of Epigenetic Heterogeneity within the Human CD49f Compartment {#sec2.6}
----------------------------------------------------------------------

The CD49f cells were sorted from cord blood derived from two individual donors, which enabled an examination of donor-specific contributions to methylation states at the single-cell level. Interestingly, this analysis revealed that that the data for single CD49f cells clustered separately by donor ([Figure 5](#fig5){ref-type="fig"}A). To investigate whether these donor-specific epigenetic differences were a result of genetic differences between the two donors, we identified genetic variants by applying MethylExtract ([@bib4]) to the donor *in silico* merged datasets. After combining non-identical homozygous variants for both donors (excluding homozygous variants involving a C or G), we masked CpGs within 200 bp of the donor-specific variants and recalculated the PD values. This decreased both inter- and intra-donor PD values, but donor-specific methylation states remained the major driver of variation within the CD49f population ([Figures 6](#fig6){ref-type="fig"}A and 6B). We also noted that the PD value increased when only CpGs within 200 bp of single-nucleotide variants (SNVs) were considered ([Figure 6](#fig6){ref-type="fig"}C). Taken together, this result suggests that genetic variation accounts only partly for the observed donor-associated epigenetic variation and that donor-specific epigenetic variation is a dominant feature across single and highly purified human CD49f cells.Figure 6Donor Variation in CD49f Cell Methylomes(A) Single CD49f cells still cluster by donor after removing CpGs within 200 bp of non-C and -G SNV locations.(B) MDS projection of PD values onto 2D space remains largely unchanged despite taking into account SNVs.(C) PD values as a function of comparisons versus cells either from the same or the other donor. Boxes are colored if only CpGs near SNVs, outside SNVs, or all CpGs were considered.

Application of PDclust separately to the methylome data for the single CD49f cells from donors 1 and 2 then enabled the identification in each of a consistent subpopulation (group 1, comprising 9% and 11%, respectively, [Figure 7](#fig7){ref-type="fig"}A) that did not correlate with expression levels of the surface markers used to isolate them (CD3, 11b, 19, 34, 38, 90, 45RA, 49f) ([Figure 7](#fig7){ref-type="fig"}B). To test the sensitivity to the depth of sequence data obtained, we then sequenced the library from donor 1 to a 4-fold greater depth (an average of 7.8 million mapped reads per cell) ([Figures S7](#mmc1){ref-type="supplementary-material"}A and S7B). Interestingly, this did not significantly alter the results ([Figure S7](#mmc1){ref-type="supplementary-material"}C), suggesting that the cell-to-cell variation was already accurately captured by the original dataset.Figure 7Heterogeneity within the Human CD49f Cell Compartment(A) A rare subset of CD49f cells (group 1, 11% and 9% of all CD49f cells for donors 1 and 2, respectively) cluster away from the rest of the cells after projection of PD values with MDS.(B) Distributions of surface markers obtained during index sorting of single cells belonging to cluster 1 or cluster 2, split by donor.(C) Observed over expected enrichment of DMRs. The ratios were calculated by dividing the fraction of DMRs that overlap each region set by the fraction of the genome each region set occupies.(D) Gene enrichment of DMRs that are hypomethylated in each comparison. The comparisons between group 1 and group 2 were separate from the comparisons between CD49f cells and published data for other CD34^+^ phenotypes. Bars are gray if their FDR-corrected binomial q value is \<0.1.(E) Example of a DMR near the *SERPING1* gene. Methylation values were smoothened for each population of cells with Bsmooth and plotted. Tick marks on the x axis represent the location of CpG dinucleotides. Computationally defined DMRs are highlighted in blue. The genes track shows high confidence protein-coding transcripts obtained from Gencode v75.See also [Figure S7](#mmc1){ref-type="supplementary-material"}.

We then took advantage of the more deeply sequenced dataset to perform an *in silico* merging of the cells previously identified as group 1 (n = 6) and group 2 (n = 63) cells. *In silico* merging of the data from the first group 1 resulted in a nearly complete recapitulation of the human methylome (17.1 M CpGs in group 1 and 27.1 M CpGs in group 2) allowing for comprehensive epigenetic annotation of the two groups. As a comparator, we performed *in silico* merging of all available CD49f cell data as well as the published hematopoietic progenitor cell (HPC) data (common lymphoid progenitors \[CLPs\], common myeloid progenitors, GMPs, multilymphoid progenitors \[MLPs\], and MPPs) ([@bib19]). As before, we estimated the smoothened methylation values of all CpG sites in the genome for each group and called DMRs. This resulted in the identification of 18,035 DMRs that were hypomethylated in group 1 compared with group 2, and 15,283 DMRs that were in the opposite state. DMRs were enriched in promoters (i.e., sequences between 2 kb upstream and 500 bp downstream of coding gene TSSs), depleted in intergenic regions, and highly enriched in evolutionarily conserved elements (Phastcon score \[[@bib54]\]; two-sided t test, p ∼ 0), suggesting that these DMRs have functional relevance ([Figure 7](#fig7){ref-type="fig"}C). GSEA of genes associated with DMRs that were hypomethylated in CD49f cells compared with HPCs showed these were enriched in pathways implicated in HSC differentiation ([Figure 7](#fig7){ref-type="fig"}D). Interestingly, DMRs hypomethylated in group 1 compared with group 2 were enriched in genes that are upregulated in leukemia ([@bib11]) and genes whose expression is upregulated in hematopoietic progenitors ([@bib31]) ([Figure 7](#fig7){ref-type="fig"}D). For example, *SERPING1*, a gene that is upregulated in acute promyeolocytic leukemia ([@bib11]) and a prognostic marker for acute myeloid leukemia ([@bib38]), was found to contain a DMR that was hypomethylated in group 1 cells ([Figure 7](#fig7){ref-type="fig"}E).

Discussion {#sec3}
==========

We describe an automated methodology for single-cell DNA methylation profiling of single cells optimized for genomic coverage. The increased coverage afforded by our methodology allowed epigenetically distinct subsets within highly purified phenotypes to be identified and distinguished from developmentally both closely and more distally related cell types. We therefore anticipate that it will have utility in dissecting biologically important, but potentially subtle, epigenetic changes in cells that drive as yet poorly understood developmental and disease processes.

Existing single-cell DNA methylation experimental protocols can be broadly categorized into those that include random priming-based genomic preamplification and those that do not. In general, single-cell experimental protocols that involve rounds of random genomic priming (e.g., five in single-cell bisulfite sequencing \[scBS-seq\], two in PBAL, one in single-nucleus methylcytosine sequencing \[snmC-seq\], versus none in single-cell whole-genome bisulfite sequencing \[scWGBS\]) result in libraries with increased fragment diversity independent of the number of subsequent PCR cycles ([@bib40]). However, challenges associated with single-cell random priming include a consistent decrease in aligned sequence fraction and increased per-cell cost. Rounds of random priming are inversely correlated with lower mapping efficiency (average 25% in scBS-seq, 38% in PBAL, 53% in snmC-seq, versus 55% in scWGBS), suggesting that external nucleic acid sources are amplified in addition to the target genome. Additional sequencing of the resulting library pools can circumvent this problem as in the case of PBAL. We have designed the PBAL approach with these limitations in mind to optimize fragment diversity through a combination of two rounds of random priming and low-cycle PCR. We have developed a qPCR-based assay that identifies failed wells from all causes prior to pooling and sequencing. Taken together, these optimizations allow for the generation of single-cell methylomes at lower cost with diversities meeting or exceeding existing published strategies.

To identify epigenetic states from stochastic and sparse measurements characteristic of single-cell methylation datasets, we have developed an analysis package (PDclust; <https://github.com/hui-tony-zk/PDclust>) that leverages the information content of single CpGs without the need to infer the methylated states of missing data. We demonstrated its application to CpGs within regulatory regions ([@bib10]) through the identification of an epigenetically distinct subpopulation of cells in two different compartments of adult mouse bone marrow (LSK and ESLAM cells) that match their known content of HSCs defined by long-term repopulating assays: ∼3% in LSKs ([@bib45]) and 40% in ESLAM cells ([@bib5], [@bib33]). Analysis of the resulting DMRs further revealed a statistically significant number of hypomethylated regions in this subgroup that were associated with genes implicated in mouse HSC function, a majority of which have also been found to be transcriptionally active in mouse HSCs ([@bib57]). This supports previous evidence of a connection between CpG methylation status and expression examined at a single-cell level ([@bib1], [@bib29]). A significant proportion of DMR-associated plasma membrane genes were also heterogeneously expressed among individual ESLAM cells including *Cd82*, a previously annotated marker of HSCs ([@bib30]), suggesting that this might be useful in conjunction with the ESLAM protocol to further enrich for HSCs from adult mouse bone marrow.

Application of PDclust to single human hematopoietic cell datasets separated them according to established phenotypes and identified rare epigenetically distinct subpopulations from which near complete reconstitution of the methylome was achieved. Interestingly, within the highly purified CD49f population we identified donor as a significant source of consistent epigenetic heterogeneity, which was reduced but not eliminated by correcting for personal genetic variants. This observation is consistent with previous reports that showed genetic diversity as related to but not accountable for all DNA methylation differences ([@bib22], [@bib58]) and suggests that *in utero* environmental differences may be encoded within the HSC compartment, as has been reported for bulk analysis ([@bib8], [@bib46]).

The ability to detect distinct epigenetic states that distinguish phenotypically defined hematopoietic cell types from a few thousand stochastically sampled CpGs in single cells is an intriguing observation with potentially broad implications. One possible explanation for this observation is that phenotype-specific methylation signatures are characterized by extensive redundancy such that distinct epigenetic states can be accurately described by only a small fraction of single-CpG methylation states. In support of such a notion, the unique components of a DNA methylation "age" signature are contained in ∼353 CpGs sites, presumably representing a random sample of a total age signature that involves many more sites not detected using the reduced representation strategies from which these signatures have been derived ([@bib27]). Regardless of the mechanism, the ability to describe epigenetic states in single cells from single-CpG measurements without the need to infer adjacent methylation states has significant implications for the design and analysis of single-cell methylation studies.

Experimental Procedures {#sec4}
=======================

This study involved animal research and is approved by the University of British Columbia under ACC certificate number A14-0091. Human cord blood cells were obtained with informed consent from mothers of normal babies according to UBC-approved protocols (UBC REB Certificate H07-01945 to C.J.E.).

Sample Preparation {#sec4.1}
------------------

Murine bone marrow of 8- to 10-week-old mice was stained using LSK or ESLAM staining cocktails ([Table S1](#mmc1){ref-type="supplementary-material"}). HSCs were then sorted using a FACSAria Fusion (Becton Dickinson, Franklin Lakes), flash-frozen, and stored at −80°C until processing. Human cord blood was obtained from two normal full-term deliveries. Cells were stained and sorted with the CD49f cocktail as described elsewhere ([@bib34], [@bib35]). Full details can be found in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

PBAL Library Construction {#sec4.2}
-------------------------

All reagents were DNaseI or UV treated to remove ambient contaminants, and all samples were processed with negative controls. All liquid handling steps were carried out on the Bravo Automated Liquid Handling Platform (Agilent Technologies, G5409A). Plates containing single cells were lysed, spiked-in with bisulfite conversion controls, and subject to automated bead-based bisulfite conversion ([@bib13]). The resulting single-stranded DNA was subject to random priming with random hexamers (3′-phosphothioate, NNNN^∗^N^∗^N) and Klenow exo- (NEB, M0212M) twice. The double-stranded DNA was then ligated with forked Illumina adapters ([@bib39]) and PCR amplified for eight cycles. Successful wells were identified by qPCR targeted to repetitive regions of the mouse or human genome, pooled, and sequenced on an Illumina HiSeq 2,500. Full details can be found in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Data Processing {#sec4.3}
---------------

The first six bases of read1 and read2 were trimmed using Trimgalore v0.4.0 and aligned using Novoalign V3.02.10 ([www.novocraft.com](http://www.novocraft.com){#intref0015}) to the mouse assembly GRCm38 (mm10) or human assembly GRCh37 (hg19). Duplicate reads were discarded using Picard V1.31 (<http://picard.sourceforge.net>), and methylation states were called using Novomethyl V1.01 ([www.novocraft.com](http://www.novocraft.com){#intref0025}). Fractional methylation was merged for each CpG dinucleotide by taking a weighted average of each cytosine using bedtools ([@bib48]). In most cases, only one base within a CpG dinucleotide had coverage. In these cases, the methylation information of the covered base was extrapolated to the other base. Processed CpG calls were imported into R (V3.3.2) for downstream analysis. We considered only autosomal CpG sites and CpG sites with a methylation value of 0% or 100%.

CNVs in 5-Mb windows were called using Control_FREEC V7.0 ([@bib7]) with default parameters. Single cells with conversion rates \<96%, mappability \<5%, \<130,000 CpGs, and containing more than 50 windows with CNVs were removed. Full details can be found in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.

Methylation of Adjacent CpGs in Single Cells {#sec4.4}
--------------------------------------------

For single cells, we randomly sampled up to 100,000 CpG sites either genome wide or within relevant genomic regions. For each randomly sampled CpG site (CpG1), we analyzed 100 CpG sites with coverage \>0 before and after CpG1 and calculated the genomic distance to CpG1 in base pairs. We also recorded whether or not each CpG had the same methylation status as CpG1, resulting in a 2-column table containing the distance and equality status for each CpG for near CpG1. After combining all of the data in these tables for every CpG1, we binned distances into 100-bp bins and calculated the mean concordance as the fraction of CpGs in each bin that were equal. For single LSK cells, we did this for the ten single cells with the most CpG coverage. For the bulk LSK cell data that were continuous, we instead calculated the absolute difference in methylation between CpG1 and all nearby CpGs, using only CpGs with coverage ≥5 to avoid low coverage biasing potential CpG methylation values.

Pairwise Dissimilarity Clustering Using PDclust {#sec4.5}
-----------------------------------------------

For each pair of single cells, we calculated the average difference in DNA methylation of all pairwise-common CpG sites to obtain PD values. For genome-wide analysis, we took into consideration all CpGs, while for each genomic region sets we only considered CpG sites that lie within those respective regions. To group cells together with similar PD values, we calculated Euclidean distances between each pair of cells using the their PD values as features and performed hierarchical clustering with Ward\'s linkage (*ward*.*D2* in R). We used PD directly as input to multidimensional scaling (*cmdscale* in R) for visualization of cells in 2D space. Cell groups were annotated manually based on their visual distinctiveness and their resulting hierarchal clustering patterns. PDclust has been packaged into an R package, which can be downloaded from <https://github.com/hui-tony-zk/PDclust>.

Differentially Methylated Region Analysis {#sec4.6}
-----------------------------------------

To group cells that belonged to the same cluster, we treated coverage of every CpG site as the number of cells with coverage at that site, and treated methylation fraction as the fraction of cells that had a methylated CpG at that site. We used Bsmooth ([@bib23]) to obtain estimated CpG methylation at all CpG sites in the genome. For each CpG comparison between the two groups, we calculated the *Z* score converted that into a two-tailed p value assuming a normal distribution (pnorm function in R) with the null hypothesis that the methylation is not different between the two CpGs. p values were multiple test-corrected using an FDR estimate, and CpGs with q value of \<0.1 were called as dCpGs. We grouped dCpGs together into DMRs if they were within 500 bp of each other and only considered DMRs with ≥3 CpGs. We split these DMRs into two groups depending on which population had the lower methylation in each pair of comparisons, and associated DMRs to the nearest protein-coding transcript. After filtering for those DMRs in intergenic regions, exon1, or the promoter (+2 kb/−0.5 kb), we removed DMRs that associated with the same gene in both groups. We then performed GSEA for all DMR-associated genes for each group using a supervised set of ontologies. Full details can be found in [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}.
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Accession Numbers {#app1}
=================

Single-cell bisulfite sequencing (raw reads and CpG methylation calls) can be accessed from the Gene Expression Omnibus at GEO: [GSE89545](ncbi-geo:GSE89545){#intref0045}. Bulk LSK data can be accessed at GEO: [GSE95697](ncbi-geo:GSE95697){#intref0050}. Human CD49f CpG methylation data can be accessed at GEO: [GSE106957](ncbi-geo:GSE106957){#intref0055}. Raw reads for the human CD49f data can be conditionally accessed from the European Genome-Phenome Archive (EGAS00001002789).
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